Prescient Therapeutics (ASX: PTX)
Live Investor Briefing
Register for an Upcoming Webcast
Please join us for a special investor briefing with Prescient Therapeutics CEO and MD Steven Yatomi-Clarke.
In the session, Steven will discuss:
- An introduction into the amazing field of CAR-T, and how Prescient’s next gen CAR-T platform, OmniCAR, is seeking to take this burgeoning cancer field to the next level.
- Our encouraging progress through clinical trials of Prescient’s foundational assets PTX-100 and PTX-200.
This is a live and interactive online session, and participants are encouraged to ask questions. Joining only requires an internet connection. Spots are limited, so secure yours today.